DOTA-(Tyr3)-Octreotate,CAS :177943-89-4
DOTA-(Tyr3)-Octreotate
Product description
DOTA-conjugated somatostatin analog for labeling with radiometals such as gallium-67 or gallium-68, indiuM-111, and yttrium-90. Potentially useful for receptor-mediated tumor imaging and peptide receptor-targeted radionuclide therapy.
Appearance | N/A |
---|---|
Molecular weight | N/A |
Purity | >90% |
Solubility | N/A |
Cas | 177943-89-4 |
Sequence | 4,7,10-Tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH (Disulfide bond) |
One letter sequence | DOTA-fCYwKTCT (Cys & Cys bridge) |
Molecular formula | C65H90N14O19S2 |
Storage | -20℃,protected from light and moisture |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 1 year |
Document
Related Product